Castle Biosciences, Inc. (CSTL) Ownership

$16.22

$0.28 (-1.7%)
Last update: 12:22 PM EST
Day's range
$16.19
Day's range
$16.48

Castle Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/07/2025 2.92 M $77.85 M   -6.38% 10.49%
VANGUARD GROUP INC 02/11/2025 1.83 M $48.84 M   4.79% 6.58%
WASATCH ADVISORS LP 02/13/2025 1.80 M $47.87 M   -1.64% 6.45%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 1.44 M $38.26 M   -6.69% 5.16%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 999.47 K $26.64 M   15.57% 3.59%
CITADEL ADVISORS LLC 02/14/2025 834.51 K $22.24 M   31.83% 3.00%
UBS GROUP AG 02/14/2025 812.60 K $21.66 M   1,401.09% 2.92%
PORTOLAN CAPITAL MANAGEMENT, LLC 02/13/2025 776.58 K $20.70 M   -38.15% 2.79%
BELLEVUE GROUP AG 02/14/2025 745.98 K $19.88 M   -40.89% 2.68%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 722.12 K $19.24 M   100.00% 2.59%
STATE STREET CORP 02/14/2025 710.21 K $18.93 M   4.44% 2.55%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 685.00 K $18.26 M   39.92% 2.46%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 628.20 K $16.75 M   0.56% 2.26%
MILLENNIUM MANAGEMENT LLC 02/14/2025 548.81 K $14.63 M   290.51% 1.97%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 547.10 K $14.58 M   9.60% 1.97%
PALISADE CAPITAL MANAGEMENT, LP 02/14/2025 503.44 K $13.42 M   0.22% 1.81%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 465.53 K $12.41 M   -14.20% 1.67%
GOLDMAN SACHS GROUP INC 02/11/2025 432.75 K $11.53 M   78.23% 1.55%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 408.65 K $10.89 M   1.85% 1.47%
BANK OF AMERICA CORP /DE/ 02/14/2025 403.55 K $10.75 M   100.03% 1.45%
KORNITZER CAPITAL MANAGEMENT INC /KS 01/31/2025 383.97 K $10.23 M   -5.71% 1.38%
ALLIANZ ASSET MANAGEMENT GMBH 02/03/2025 322.37 K $8.59 M   356.92% 1.16%
AMERIPRISE FINANCIAL INC 02/14/2025 316.04 K $8.42 M   -9.50% 1.14%
MORGAN STANLEY 02/14/2025 306.68 K $8.17 M   -22.74% 1.10%
PARKMAN HEALTHCARE PARTNERS LLC 02/14/2025 304.63 K $8.12 M   2.89% 1.09%
NORTHERN TRUST CORP 02/14/2025 284.59 K $7.58 M   8.65% 1.02%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 258.87 K $6.90 M   -5.79% 0.93%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/14/2025 252.92 K $6.74 M   -61.81% 0.91%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 249.13 K $6.64 M   100.00% 0.89%
NEXT CENTURY GROWTH INVESTORS LLC 02/13/2025 235.21 K $6.27 M   0.48% 0.84%
INTRINSIC EDGE CAPITAL MANAGEMENT LLC 02/14/2025 232.71 K $6.20 M   9.40% 0.84%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 217.54 K $5.80 M   276.08% 0.78%
CAPTRUST FINANCIAL ADVISORS 02/14/2025 215.32 K $5.74 M   2,567.52% 0.77%
TREXQUANT INVESTMENT LP 02/12/2025 203.57 K $5.43 M   27.53% 0.73%
SILVERCREST ASSET MANAGEMENT GROUP LLC 02/14/2025 199.95 K $5.33 M   -0.98% 0.72%
NEW YORK STATE COMMON RETIREMENT FUND 01/31/2025 189.10 K $5.04 M   2.81% 0.68%
ADVISORS CAPITAL MANAGEMENT, LLC 02/13/2025 178.94 K $4.77 M   6.56% 0.64%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 177.54 K $4.73 M   -6.84% 0.64%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 168.71 K $4.50 M   1.97% 0.61%
SHELTON CAPITAL MANAGEMENT 02/13/2025 164.01 K $4.37 M   0.00% 0.59%
ALGERT GLOBAL LLC 02/14/2025 149.49 K $3.98 M   11.29% 0.54%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/14/2025 134.78 K $3.59 M   -72.85% 0.48%
HARBOR CAPITAL ADVISORS, INC. 01/10/2025 118.50 K $3.16 M   -23.01% 0.43%
GRANAHAN INVESTMENT MANAGEMENT, LLC 02/14/2025 110.82 K $2.95 M   -73.94% 0.40%
JPMORGAN CHASE & CO 02/12/2025 107.94 K $2.88 M   55.51% 0.39%
D. E. SHAW & CO., INC. 02/14/2025 90.56 K $2.41 M   100.00% 0.33%
BANK OF NEW YORK MELLON CORP 02/04/2025 84.46 K $2.25 M   10.29% 0.30%
BIRCHVIEW CAPITAL, LP 02/14/2025 78.00 K $2.08 M   34.48% 0.28%
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 02/19/2025 74.13 K $1.98 M   -16.62% 0.27%
FRANKLIN RESOURCES INC 02/12/2025 73.64 K $1.96 M   6.13% 0.26%

Castle Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 93 institutional investors and hedge funds held shares of Castle Biosciences, Inc.. The most heavily invested institutionals were:

IFP Advisors, Inc: 0

FEDERATED HERMES, INC.: 0

MCF Advisors LLC: 0

LPL Financial LLC: 0

FOX RUN MANAGEMENT, L.L.C.: 0

Lisanti Capital Growth, LLC: 0

94.90% of Castle Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 8.45 M shares in the last 24 months. This purchase volume represents approximately $137.21 M in transactions.